Dr. Debbie Lin is an Executive in Residence at DigitalDx Ventures, a diagnostics focused fund in the Bay Area. She has over 14 years of business leadership experience in multinational environments, including the US, Europe and Asia. Debbie’s forte is new business model strategy, business development, venture capital in healthcare and medtech with a focus on scientific product development, value proposition refinement, and market access.
Previously, Debbie served in various roles at Boehringer Ingelheim. As Executive Director for Boehringer Ingelheim Venture Fund, Debbie was accountable for digital health investments, board directorship and digital health strategy in North America. Before her role at the Venture Fund, she was Global Director of Corporate Development where she crafted new business models for healthcare in major global markets.
She has also held operational roles in field-based Health Economics and Medical Affairs working with national payers, regional providers and opinion leaders. She supported more than 5 drug launches and a variety of disease indications. Debbie is an Adjunct Faculty Advisor at UCLA Anderson School of Business and a mentor at Stanford’s MedicineX and NYU’s Endless Frontier Labs.
Debbie holds a PhD, Bioinformatics Pharmacogenomics from University of California, San Francisco and a Master’s degree and MSc Engineering degree from Stanford University School of Engineering.